2023-06-30 11:57:31 ET
- Abcam ( NASDAQ: ABCM ) ADRs rose 4% on a report that the biotechnology supplier is seeing initial interest from Danaher ( DHR ) and Agilent Technologies ( A ).
- Abcam ( ABCM ) has also separately reached out to other companies, including Germany's Merck KGaA ( OTCPK:MKGAF ), to see their interest in a possible deal, according to a Bloomberg report, which cited people familiar with the matter. Several private equity firms are also evaluating the company.
- Abcam ( ABCM ) said a week ago it would review strategic alternatives after receiving takeover interest.
- Developing story ...
For further details see:
Abcam gains on report it's seeing takeover interest from Danaher, Agilent